Bayer | BAYN - Interest Expense On Debt


Bayer reported EUR675M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Air Liquide EUR 125.9M 3.6M Dec/2025
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 54M 3M Dec/2025
Amarin USD 3K 5K Dec/2024
Arkema EUR 11M 582M Jun/2025
AstraZeneca USD 484M 181M Dec/2025
BASF EUR 236M 15M Dec/2025
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 7.5M 19.5M Jun/2025
Corteva USD 46M 0 Dec/2025
Covestro EUR 33M 1000K Sep/2025
Essilor EUR 147M 102.5M Jun/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 85M 8.1M Dec/2025
Genmab DKK 10M 27M Dec/2025
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Johnson Matthey GBP 75M 4M Jun/2024
Linde USD 64M 3M Sep/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 121M 5M Dec/2025
Novartis USD 304M 23M Dec/2025
Nutrien USD 183M 13M Dec/2025
Philips EUR 109M 31M Dec/2025
PPG Industries USD 58M 7M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
SAP EUR 517M 205M Dec/2025
Solvay EUR 25M 0 Dec/2025
UCB EUR 49M 29M Dec/2025
Umicore EUR 36.5M 33.15M Dec/2024
Vinci EUR 661M 69M Jun/2025